Back
Akebia Therapeutics Stock Price Chart
10 stocks to buy for the next leg of this rally
Get the full list here FREE
Buy
72
AKBA
Akebia Therapeutics
Last Price:
$3.02
Seasonality Move:
-3.63%
7 Day Trial
ALL ACCESS PASS
$
7
10 Best Stocks to Own in 2025
Get your copy now FREE!-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing slight selling pressure.
Akebia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.88 | Buy |
| 20-day SMA: | 2.63 | Buy |
| 50-day SMA: | 2.26 | Buy |
| 200-day SMA: | 1.88 | Buy |
| 8-day EMA: | 2.85 | Buy |
| 20-day EMA: | 2.66 | Buy |
| 50-day EMA: | 2.39 | Buy |
| 200-day EMA: | 1.95 | Buy |
Akebia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 71.14 | Buy |
| Chaikin Money Flow: | -462315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.36 - 2.8) | Buy |
| Bollinger Bands (100): | (1.82 - 2.48) | Buy |
Akebia Therapeutics Technical Analysis
| May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics Stock
Is Akebia Therapeutics Stock a Buy?
-
Akebia Therapeutics share price is 3.01 while AKBA 8-day simple moving average is 2.88, which is a Buy signal.
-
The stock price of AKBA is 3.01 while Akebia Therapeutics 20-day SMA is 2.63, which makes it a Buy.
-
Akebia Therapeutics 50-day simple moving average is 2.26 while AKBA share price is 3.01, making it a Buy technically.
-
AKBA stock price is 3.01 and Akebia Therapeutics 200-day simple moving average is 1.88, creating a Buy signal.
AKBA Technical Analysis vs Fundamental Analysis
Buy
72
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy or a Sell?
-
Akebia Therapeutics stock is rated a BuyThe current Akebia Therapeutics [AKBA] share price is $3.01. The Score for AKBA is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
Akebia Therapeutics Stock Info
Market Cap:
790.5M
Price in USD:
3.01
Share Volume:
7.6M
Akebia Therapeutics 52-Week Range
52-Week High:
3.14
52-Week Low:
0.80
Buy
72
Akebia Therapeutics (AKBA)
is a Buy
Akebia Therapeutics Share Price Forecast
-
What is the Akebia Therapeutics stock price today?The Akebia Therapeutics stock price is 3.01 USD today.
-
Will AKBA stock go up or go down?Akebia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akebia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics is not overvalued.
Is Akebia Therapeutics Stock a Buy?
-
Akebia Therapeutics share price is 3.01 while AKBA 8-day exponential moving average is 2.85, which is a Buy signal.
-
The stock price of AKBA is 3.01 while Akebia Therapeutics 20-day EMA is 2.66, which makes it a Buy.
-
Akebia Therapeutics 50-day exponential moving average is 2.39 while AKBA share price is 3.01, making it a Buy technically.
-
AKBA stock price is 3.01 and Akebia Therapeutics 200-day simple moving average is 1.95, creating a Buy signal.
Fundamental Analysis of Akebia Therapeutics
Is Akebia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.12 per share, an increase this year of $0.17 per share, and an increase next year of $0.51 per share.
Technical Analysis of Akebia Therapeutics
Should I short Akebia Therapeutics stock?
-
AKBA Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Akebia Therapeutics is a Buy
-
Akebia Therapeutics Relative Strength Index (RSI) is 71.14, which suggest Akebia Therapeutics is overbought
-
The Bollinger Bands (25) for Akebia Therapeutics is (2.36 - 2.8), which suggest Akebia Therapeutics is a Buy
-
The Bollinger Bands (100) for Akebia Therapeutics is (1.82 - 2.48), which suggest Akebia Therapeutics is a Buy
* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.